tiprankstipranks
Advertisement
Advertisement
Analyst Maintains Buy Rating and $20 Price Target on Erasca as ERAS-0015 Data Bolster Foundational pan‑RAS Therapy Thesis
PremiumRatingsAnalyst Maintains Buy Rating and $20 Price Target on Erasca as ERAS-0015 Data Bolster Foundational pan‑RAS Therapy Thesis
9d ago
Closing Bell Movers: Trex up 6% after positive Q2 pre-announcement
Premium
The Fly
Closing Bell Movers: Trex up 6% after positive Q2 pre-announcement
9d ago
Erasca Reports Promising ERAS-0015 Data in Solid Tumors
Premium
Company Announcements
Erasca Reports Promising ERAS-0015 Data in Solid Tumors
9d ago
Erasca initiated with Early Stage Biotech at Goldman Sachs
PremiumThe FlyErasca initiated with Early Stage Biotech at Goldman Sachs
10d ago
Erasca Stockholders Reelect Directors and Ratify Auditors
Premium
Company Announcements
Erasca Stockholders Reelect Directors and Ratify Auditors
22d ago
Erasca upgraded to Neutral from Underperform at BofA
Premium
The Fly
Erasca upgraded to Neutral from Underperform at BofA
2M ago
Midday Fly By: Dream Finders offers to buy Beazer, Fox reports Q3 beat
PremiumThe FlyMidday Fly By: Dream Finders offers to buy Beazer, Fox reports Q3 beat
2M ago
Erasca enters AURORAS-1 clinical trial pact, supply agreement with Merck
Premium
The Fly
Erasca enters AURORAS-1 clinical trial pact, supply agreement with Merck
2M ago
Erasca recent share selloff overdone, says JPMorgan
Premium
The Fly
Erasca recent share selloff overdone, says JPMorgan
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100